0.0650
-0.0040
(-5.80%)
At close: January 17 at 3:59:16 PM GMT+11
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,670.0000
8,670.0000
7,285.0000
7,154.0000
5,105.0000
Cost of Revenue
3,910.0000
3,910.0000
3,969.0000
4,187.0000
2,881.0000
Gross Profit
4,760.0000
4,760.0000
3,316.0000
2,967.0000
2,224.0000
Operating Expense
8,750.0000
8,750.0000
9,227.0000
10,264.0000
9,990.0000
Operating Income
-3,990.0000
-3,990.0000
-5,911.0000
-7,297.0000
-7,766.0000
Net Non Operating Interest Income Expense
388.0000
388.0000
-223.0000
-322.0000
-325.0000
Other Income Expense
155.0000
155.0000
172.0000
5,261.0000
-1,199.0000
Pretax Income
-3,447.0000
-3,447.0000
-5,848.0000
-2,329.0000
-9,236.0000
Tax Provision
4.0000
4.0000
6.0000
5.0000
3.0000
Net Income Common Stockholders
-3,451.0000
-3,451.0000
-5,854.0000
-2,334.0000
-9,239.0000
Basic EPS
-0.10
--
-0.23
-0.11
-1.24
Diluted EPS
-0.10
--
-0.23
-0.11
-1.24
Basic Average Shares
34,851.7150
--
25,440.7730
20,588.5570
7,455.1070
Diluted Average Shares
34,851.7150
--
25,440.7730
20,588.5570
7,455.1070
Net Income from Continuing & Discontinued Operation
-3,451.0000
-3,451.0000
-5,854.0000
-2,334.0000
-9,239.0000
Normalized Income
-3,451.0000
-3,451.0000
-5,854.0000
-2,334.0000
-9,239.0000
Interest Income
471.0000
471.0000
73.0000
--
9.0000
Interest Expense
83.0000
83.0000
296.0000
322.0000
334.0000
Net Interest Income
388.0000
388.0000
-223.0000
-322.0000
-325.0000
EBIT
-3,364.0000
-3,364.0000
-5,552.0000
-2,007.0000
-8,902.0000
EBITDA
-3,364.0000
-3,364.0000
-5,438.0000
-1,978.0000
-8,848.0000
Reconciled Cost of Revenue
3,910.0000
3,910.0000
3,969.0000
4,187.0000
2,881.0000
Reconciled Depreciation
--
--
114.0000
29.0000
54.0000
Net Income from Continuing Operation Net Minority Interest
-3,451.0000
-3,451.0000
-5,854.0000
-2,334.0000
-9,239.0000
Normalized EBITDA
-3,364.0000
-3,364.0000
-5,438.0000
-1,978.0000
-8,848.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
12/31/2020 - 3/27/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IRX.AX InhaleRx Limited
0.0270
+8.00%
HMD.AX HeraMED Limited
0.0180
+5.88%
UBI.AX Universal Biosensors, Inc.
0.0950
0.00%
AVR.AX Anteris Technologies Global Corp.
9.64
+4.22%
IMR.AX Imricor Medical Systems, Inc.
1.3900
+6.92%
EBR.AX EBR Systems, Inc.
1.4850
+4.58%
AVH.AX AVITA Medical, Inc.
2.8000
-2.10%